default author photo

Stella Namukwaya

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

175

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

BREATHER Plus Clinical Trial Design: A Randomised Non-Inferiority Trial Evaluating the Efficacy, Safety and Acceptability of Short Cycle (Five Days on, Two Days Off) Dolutegravir/Tenofovir-Based Triple Antiretroviral Therapy (Art) Compared to Daily Art in Virologically Suppressed Adolescents Living with HIV Aged 12 to <20 Years in Sub-Saharan Africa

Number of pages: 44 Posted: 04 Mar 2025
Fredrick Katongole, Tiyara Arumugam, Angus Jennings, Constantine Mutata, Patrick Ssebunya, Charity Wamboi, Alexandra Green, Mutsa Bwakura Dangarembizi, Cissy Kityo, Abraham M. Siika, Moherndran Archary, Lungile Jafta, Stella Namukwaya, Janet Seeley, Henry Mugerwa, Simon Walker, Naomi Apoto, Margaret J. Thomason, Deborah Ford, Sarah Pett and Adeodata R. Kekitiinwa
affiliation not provided to SSRN, Enhancing Care Foundation, University College London - MRC Clinical Trials Unit, affiliation not provided to SSRN, affiliation not provided to SSRN, Moi University, University College London - MRC Clinical Trials Unit, affiliation not provided to SSRN, Joint Clinical Research Centre, Moi University, University of KwaZulu-Natal, Fondazione Penta ETS, affiliation not provided to SSRN, London School of Hygiene & Tropical Medicine - Department of Global Health and Development, Joint Clinical Research Centre, University of York, Baylor University - Children's Foundation Uganda, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit and Baylor University - Children's Foundation Uganda
Downloads 96 (725,554)

Abstract:

Loading...

clinical trial, HIV, adolescents, short-cycle, antiretroviral, dolutegravir

2.

Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): a randomised, open-label, non-inferiority, 96-week trialevaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen (CAB/RPV) compared to daily oral therapy (DTG based TDF or TAF with 3TC or FTC backbone) in virologically suppressed adolescents living with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa

Number of pages: 34 Posted: 30 Oct 2025
Diana Anena, Elizabeth Chappell, Rashidah Nazzinda, Cecilia Kiilu, Moses Chitsamatanga, Tiyara Arumugam, Alexandra Green, Cissy Kityo, Mutsa F. Bwakura-Dangarembizi, Abraham M. Siika, Moherndran Archary, Lungile Jafta, Stella Namukwaya, Janet Seeley, George Patrick Akabwai, Henry Mugerwa, Lisanne Bevers, David Burger, Simon Walker, Alasdair Bamford, Annabelle South, Naomi Apoto, Molly Bush, Margaret J. Thomason, Ben Spittle, Deborah Ford, Adeodata R. Kekitiinwa and Sarah Pett
affiliation not provided to SSRN, affiliation not provided to SSRN, Joint Clinical Research Centre, Moi University, affiliation not provided to SSRN, Enhancing Care Foundation, University College London - MRC Clinical Trials Unit, Joint Clinical Research Centre, University of Zimbabwe - Clinical Trials Research Centre, Moi University, University of KwaZulu-Natal, Fondazione Penta ETS, affiliation not provided to SSRN, London School of Hygiene & Tropical Medicine - Department of Global Health and Development, Baylor University - Children's Foundation Uganda, Joint Clinical Research Centre, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Radboud University Medical Center, University of York, University College London - Infection, Immunity and Inflammation Research & Teaching Department, University College London - MRC Clinical Trials Unit, Baylor University - Children's Foundation Uganda, affiliation not provided to SSRN, University College London - MRC Clinical Trials Unit, affiliation not provided to SSRN, University College London - MRC Clinical Trials Unit, Baylor University - Children's Foundation Uganda and University College London - MRC Clinical Trials Unit
Downloads 79 (830,555)

Abstract:

Loading...

HIV, adolescents, cabotegravir and rilpivirine, antiretroviral therapy, injectable, clinical trial